ImmunityBio, Inc. — Cash Flow Charts
2 years of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Capital Allocation
How management deploys cash: investing in the business (Capex + M&A) vs returning to shareholders (Buybacks + Dividends).
Capital Allocation Waterfall
Buybacks vs Stock-Based Comp
Net Debt Issuance
Cash Flow
Cash Flow by Activity
Operating Cash Flow
$-305M
Free Cash Flow
$-309M
Investing Cash Flow
$-150M
Financing Cash Flow
$400M
Capex
$4M
Acquisitions
—
Stock Buybacks
—
Stock-Based Comp
$37M
Debt Repaid
$1M
D&A
$16M